cbdMD, Inc. income statement YCBD

Annual Quarterly

In Q3 of fiscal 2026, the quarter ended Jun 30, 2026, cbdMD, Inc. reported revenue of $5.6 million, up 20.6% from the same quarter a year earlier. It recorded a net loss of $1.1 million. The operating loss came to $1.1 million, an operating margin of -20.4%.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Jun 30, 2026	Q3 FY2026 Jun 30, 2026	Q2 FY2026 Mar 31, 2026	Q4 FY2025 Sep 30, 2025	Q3 FY2025 Jun 30, 2025	Q2 FY2025 Mar 31, 2025	Q1 FY2025 Dec 31, 2024	Q4 FY2024 Sep 30, 2024	Q3 FY2024 Jun 30, 2024
Revenue	21 +10.0%	6 +20.6%	6 +18.8%	5 +3.6%	5 -11.0%	5 -1.4%	5 -4.9%	5 -21.0%	5 -19.9%
Cost of revenue	9 +20.0%	3 +41.7%	2 +33.1%	2 -7.6%	2 +0.3%	2 -0.3%	2 -5.8%	2 -2.7%	2 -22.1%
Gross profit	12 +3.7%	3 +7.3%	3 +10.1%	3 +13.2%	3 -16.8%	3 +14.7%	3 -4.4%	2 -30.9%	3 -11.5%
Operating income	-3 -61.9%	-1 -25.0%	-1 -64.8%	-1 -116.6%	-1 -136.8%	-0 +68.7%	-0 +91.9%	-0 +97.9%	-0 +79.1%
Pretax income	-3 -90.8%	-1 -25.9%	-1 -66.0%	-1 -345.0%	-1 -294.7%	-0 +84.0%	0 +101.5%	-0 +99.0%	0 +126.0%
Net income	-3 -90.8%	-1 -25.9%	-1 -66.0%	-1 -345.0%	-1 -294.7%	-0 +84.0%	0 +101.5%	-0 +99.0%	0 +126.0%
Net income to common	-3 +36.5%	-1 +2.5%	-1 +40.8%	-1 +41.1%	-1 -127.2%	-1 +63.1%	-1 +50.7%	-1 +93.2%	-1 +80.5%
Basic EPS	-0.32 +86.8%	-0.11 +47.6%	-0.08 +95.8%	-0.08 +93.7%	-0.21 +97.6%	-1.90 +82.5%	-1.73 -158.2%	-1.21 +92.7%	-8.93 -669.8%
Diluted EPS	—	—	—	—	—	—	—	—	-0.15 +87.1%
Weighted average shares, basic	10 +382.6%	11 +83.6%	10 +1241.7%	9 +832.7%	6 +1187.7%	1 +110.3%	1 -80.8%	1 -6.7%	0 -81.1%
Other measures
Depreciation and amortization	0 -46.4%	0 -50.1%	0 -52.8%	0 -34.9%	0 -22.6%	0 -19.6%	0 -3.7%	0 +5.1%	0 -42.7%
EBITDA	-3 -92.9%	-1 -33.1%	-1 -93.3%	-1 -196.0%	-1 -205.4%	-0 +72.7%	0 +102.1%	-0 +98.6%	-0 +83.5%
Margins
Gross margin	57.68%	54.69%	57.75%	58.83%	61.45%	62.31%	66.50%	53.85%	65.78%
Operating margin	-13.87%	-20.36%	-14.20%	-14.53%	-19.64%	-10.23%	-1.69%	-6.95%	-7.38%
Pretax margin	-13.80%	-20.30%	-14.15%	-14.40%	-19.43%	-10.12%	0.30%	-3.35%	8.89%
Profit margin	-13.80%	-20.30%	-14.15%	-14.40%	-19.43%	-10.12%	0.30%	-3.35%	8.89%
EBITDA margin	-12.85%	-19.56%	-13.41%	-13.03%	-17.71%	-8.24%	0.40%	-4.56%	-5.16%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844)
Listed as: YCBD (NYSE)
Fiscal year ends: September 30
Incorporated in: NC
Headquarters: Charlotte, NC
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1644903
Former names: Level Brands, Inc. (until May 1, 2019); LEVEL BEAUTY GROUP, INC. (until Sep 27, 2016)

Other Perfumes, Cosmetics & Other Toilet Preparations companies

All 22 Perfumes, Cosmetics & Other Toilet Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.